Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome and evolution of the shade-requiring medicinal herb Panax ginseng.
Kim NH, Jayakodi M, Lee SC, Choi BS, Jang W, Lee J, Kim HH, Waminal NE, Lakshmanan M, van Nguyen B, Lee YS, Park HS, Koo HJ, Park JY, Perumal S, Joh HJ, Lee H, Kim J, Kim IS, Kim K, Koduru L, Kang KB, Sung SH, Yu Y, Park DS, Choi D, Seo E, Kim S, Kim YC, Hyun DY, Park YI, Kim C, Lee TH, Kim HU, Soh MS, Lee Y, In JG, Kim HS, Kim YM, Yang DC, Wing RA, Lee DY, Paterson AH, Yang TJ. Kim NH, et al. Among authors: hyun dy. Plant Biotechnol J. 2018 Nov;16(11):1904-1917. doi: 10.1111/pbi.12926. Epub 2018 May 25. Plant Biotechnol J. 2018. PMID: 29604169 Free PMC article.
Optimal timing of percutaneous coronary intervention for non-ST elevated myocardial infarction with congestive heart failure.
Lim Y, Kim MC, Ahn JH, Lee SH, Hyun DY, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Choi IJ, Choo EH, Lim S, Hwang BH, Park MW, Kim CJ, Park CS, Kim HY, Chang K, Ahn Y. Lim Y, et al. Among authors: hyun dy. Cardiovasc Revasc Med. 2024 Apr 25:S1553-8389(24)00447-0. doi: 10.1016/j.carrev.2024.04.295. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38679500
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Lee SH, Oh S, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Jeong YH, Park Y, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Lee JH, Yoo SY, Ahn Y; OPTION-STEMI Investigators. Kim MC, et al. Among authors: hyun dy. Am Heart J. 2024 Apr 18;273:35-43. doi: 10.1016/j.ahj.2024.03.017. Online ahead of print. Am Heart J. 2024. PMID: 38641031 Free article.
Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study.
Sim DS, Hyun DY, Hong YJ, Kim JH, Ahn Y, Jeong MH, Lee SR, Chae JK, Park KH, Koh YY, Yun KH, Oh SK, Joo SJ, Hwang SH, Park JP, Rhew JY, Kim SH, Cho JH, Lee SU, Kang DG. Sim DS, et al. Among authors: hyun dy. Chonnam Med J. 2024 Jan;60(1):78-86. doi: 10.4068/cmj.2024.60.1.78. Epub 2024 Jan 25. Chonnam Med J. 2024. PMID: 38304131 Free PMC article.
Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model.
Park DS, Oh S, Jin YJ, Na MH, Kim M, Kim JH, Hyun DY, Cho KH, Hong YJ, Kim JH, Ahn Y, Hermida-Prieto M, Vázquez-Rodríguez JM, Gutiérrez-Chico JL, Mariñas-Pardo L, Lim KS, Park JK, Byeon DH, Cho YN, Kee SJ, Sim DS, Jeong MH. Park DS, et al. Among authors: hyun dy. Tissue Eng Regen Med. 2024 Jan;21(1):53-64. doi: 10.1007/s13770-023-00608-y. Epub 2023 Nov 16. Tissue Eng Regen Med. 2024. PMID: 37973692
90 results